Wockhardt’s ‘miracle drug’ Zaynich: Can it revive the antibiotics market and the company’s fortunes?
Wockhardt’s experimental drug, Zaynich, has shown impressive results, achieving a 100% cure rate in clinical trials for ...
Medscape4h
Drugmakers Are Limiting Cancer Patients’ Access to Financial Lifelines. Why?
Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...
Pharmaceutical Technology5h
Be Bio secures $92m for haemophilia B and hypophosphatasia treatments
Be Biopharma has secured $92m in a Series C financing round to advance its clinical programmes for haemophilia B and ...
MedCity News9h
Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
WHSmith plans to close two popular stores in fresh blow to high street
WHSmith will bid farewell to two hugely popular sites this year, adding to the shuttered buildings that are sitting empty on ...
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...
NationofChange21h
FTC report exposes big pharma middlemen inflating drug prices by up to 7,736%
Report reveals big pharma middlemen inflating drug prices, reaping billions in excess revenue. • The Federal Trade Commission (FTC) released a report showing that pharmacy benefit managers (PBMs) ...
WREG22h
Black-owned pharmacy combats ‘pharmacy desert’
Big-box drugstores like CVS and Walgreens are closing thousands of stores across the country, including some in the St. Louis ...
FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...